Introduction

DNA-dependent protein kinase (DNA-PK) functions in double-strand break repair and is necessary for immunoglobulin [V(D)J] recombination (reviewed in
. This multiprotein enzyme contains a heterodimeric DNA-end binding protein, Ku (70 and 80 kDa subunits) and a catalytic protein, DNA-PK cs (470 kDa). DNA-PK cs is related by sequence homology to phosphatidylinositol (PI) 3-kinases, but DNA-PK is a serine/threonine protein kinase that has no known kinase activity towards lipids . Ku binds free DNA ends and single-strand/ double-strand transitions (Blier et al., 1993; Falzon et al., 1993) which result from DNA damage or occur as recombination intermediates. Ku subsequently recruits DNA-PK cs (Suwa et al., 1994) and is presumed to phosphorylate other DNA-bound proteins involved in DNA repair, recombination, replication, and/or transcription (Anderson and Lees-Miller, 1992; Anderson, 1993; 1994; Chu, 1997) .
Although the genetic location of the DNA-PK cs gene (Sipley et al., 1995; Thompson and Jeggo, 1995) and the sequence of the 13.5 kb mRNA are known and putative promoter elements have been identi®ed (Connelly et al., 1998) , little is understood about the mechanisms that control expression of this immense gene. DNA-PK cs appears to be constitutively expressed and is not up-regulated in response to DNA damage (Anderson and Carter, 1996) , but control elements other than DNA regulatory domains, such as those involved in mRNA stability, have not been identi®ed. In spite of the very large size of its transcript, only one alternately spliced mRNA product has been identi®ed. This smaller transcript lacks a small exon encoding a 31 amino acid segment from the amino-terminus of the kinase domain (Blunt et al., 1996; Connelly et al., 1996) . Absence of DNA-PK activity confers a radiosensitive phenotype (LeesMiller et al., 1995; Blunt et al., 1996) and as radiosensitivity would be a useful characteristic to induce in malignant cells, an understanding of the mechanisms that control expression of this gene may ultimately lead to a new target in cancer therapy.
We previously isolated a radiation-sensitive human cell line, M059J, derived from a malignant glioma, which lacks the catalytic subunit of this DNA-PK complex. M059J cells are extremely sensitive to radiation and show a reduced ability to rejoin DNA double-strand breaks (dsb). A second cell line, M059K, derived from the same biopsy, contains normal amounts of the DNA-PK cs protein and associated activity; this line is relatively radioresistant and DNA dsb repair pro®cient (Allalunis-Turner et al., 1993; . Earlier work indicated that although both M059J and M059K contain an unrearranged DNA-PK cs gene, M059J not only lacks the DNA-PK cs protein but also the cognate transcript .
Mutations which cause a complete absence of transcription often reside in the promoter region and prevent the initiation of transcription (Mitchell and Tjian, 1989) ; however, mutations that cause rapid turnover of an otherwise stable mRNA also can lead to an apparent absence of that mRNA (reviewed in Jacobson and Peltz, 1996) . In this study, we demonstrate that the DNA-PK cs gene is normally transcribed at a very low rate, but the processed transcript is intrinsically exceedingly stable. Transcription of the DNA-PK cs gene proceeds at this same normal rate in our radiosensitive M059J cell line, but in these cells this transcript exhibits a greatly reduced stability that accounts for the previously undetectable level of message. Furthermore, the alternately spliced DNA-PK cs message lacking the 31 amino acid kinase domain encoding exon is present in all cell lines tested to date with the sole exception of M059J cells.
Results
Sequencing of the promoter region of the DNA-PK cs gene in M059J and M059K cells Previously we showed that the radiosensitive phenotype of M059J cells was attributable to a lack of DNA-PK activity and that the DNA-PK cs transcript could not be detected by Northern analysis. The sister cell line, M059K, derived from the same glioma biopsy, has a normal response to radiation and contains normal levels of DNA-PK activity and the DNA-PK cs transcript . We postulated, therefore, that the promoter region of the DNA-PK cs gene was a reasonable place to begin looking for the genetic defect in M059J cells. PCR products were generated from genomic DNA extracted from both cell types. This PCR product encompasses the region from 7669 relative to the transcriptional start site to +168 within the ®rst exon and covers all known putative promoter elements (Connelly et al., 1998) . We were unable to ®nd any sequence discrepancy between M059J and M059K; both gave sequences identical to the published sequence from normal cells for this segment Connelly et al., 1998) (data not shown).
M059J cells do contain DNA-PK cs transcripts
Using RT ± PCR and the DNA-PK cs -speci®c primers, PK10 and PK18, which corresponds to DNA-PK cs sequence in exons 1 and 11, respectively, we analysed DNA-PK cs expression in a panel of glioma cell lines including M059J, which previously was shown by Northern analysis to lack the DNA-PK cs transcript. Surprisingly, a PCR product of the correct size, 1008 bp, was generated from M059J cDNA ( Figure  1 ). To con®rm that this product was an authentic DNA-PK cs -derived product, *200 bp were sequenced and found to be identical to the published sequence. PK10 and PK18 generate a PCR product from the extreme 5' end of the DNA-PK cs transcript. We therefore chose a second primer pair, PK16 and PK17, which correspond to sequences in the 3' region of the transcript, including the 3' region of the kinase domain and most of the 3' untranslated region (UTR). Again, PCR products of the expected size, 1045 bp, were generated from both M059J and M059K cDNAs ( Figure 1 ) and sequence analysis con®rmed their authenticity.
Our earlier Northern analysis used a DNA-PK cs probe of 442 bp with sequences complementary to 6045 ± 6486 of the cDNA . It therefore seemed possible that DNA-PK cs mRNA had not been detected in M059J cells because this region of the mRNA was absent. To address this possibility, we made primers, PK21 and PK22, encompassing this area and a PCR product of the expected size, 344 bp, was generated from both M059J and M059K cells (Figure 1 ).
M059J cells contain approximately 20-fold fewer DNA-PK cs transcripts than do either M059K cells or the normal human ®broblast strain, GM38
Detection of DNA-PK cs mRNA in M059K cells by Northern analysis required 10 mg of poly(A) + mRNA and exposure for 7 days to X-ray ®lm, whereas b-actin mRNA could be detected on the same blot within 1 h . Therefore, a relatively small reduction in the amount of DNA-PK cs mRNA could prevent detection in M059J cells by this method. The expression of a gene can be quantitatively compared between cell lines or cell types from standard curves produced by simultaneous PCR on serial dilutions of cDNA reactions (Horikoshi et al., 1992) . At approximately high dilutions, a linear relationship exists between the template dilution and the amount of PCR product, but at lower dilutions, when the concentration of cDNA template corresponding to the mRNA species of interest is ample, the reaction saturates. This information can be used to determine the relative amounts of an mRNA species in dierent cell lines. Hence, quantitative PCR was employed to determine the relative amount of DNA-PK cs transcripts in our two glioma cell lines and a normal skin ®broblast strain.
cDNAs were synthesized from total RNA extracted from M059J, M059K and GM38, and DNA-PK cs segments were ampli®ed by PCR from serially diluted templates. We then generated standard curves to compare the amounts of DNA-PK cs mRNA to an internal standard corresponding to a segment of bactin mRNA generated from the same cDNA template preparation (Figure 2 ). b-actin was chosen as the internal standard because we showed previously that its concentration was equivalent in the M059J and K cell lines . The amount of DNA-PK cs product generated from equivalent dilutions of Figure 1 Ampli®cation of the DNA-PK cs cDNA fragments from M059J and M059K cells by RT ± PCR. Reactions were performed on total mRNA extracted from M059J (two independent preparations) or M059K (two independent preparations) and product size was determined by 2% agarose gel electrophoresis using a 1 kb marker ladder (Gibco/BRL). PK10-PK18 ampli®es a 1008 bp fragment; PK16-PK17 generates a 1045 bp product; PK21-PK22 ampli®es a 344 bp fragment. No products were obtained when genomic DNA from either cell line was substituted for cDNA since all primer pairs span at least one large intron. For example, the primer pair PK10-PK18 generates a 1008 bp RT ± PCR product which spans the ®rst 11 exons. The genomic product would be 415 kb cDNA template in the linear range was indistinguishable for M059K and GM38 cells (data not shown), whereas it was approximately 20-fold less for M059J cells, indicating that DNA-PK cs mRNA is approximately 20-fold less abundant in M059J compared to M059K cells or GM38 cells.
DNA-PK cs mRNA synthesis is normal in M059J cells
At least two explanations could account for subnormal levels of a particular mRNA: (i) the message is transcribed at a reduced rate or; (ii) the mRNA is less stable. To determine transcription rates throughout the DNA-PK cs gene, we performed nuclear run-on transcription assays on nuclei isolated from M059J and M059K cells (Figure 3 ). Brie¯y, nuclei from both cell lines were incubated with 32 P-UTP to label nascent transcripts, the isolated RNAs were hybridized to single-stranded DNA probes immobilized on ®lters, and bound RNA was detected by autoradiography. The g-actin, histone H2b and c-myc 5' regions were transcribed at similar rates in both cell lines (Figure 3 ). The DNA-PK cs gene was also transcribed at similar rates in both cell lines in the mid-and 3' regions of the gene. Interestingly, M059K cells exhibit a gradient of transcription, with an apparent higher rate of transcription at the 5'-end than in M059J cells, suggesting dierences in transcriptional elongation and initiation rates between the two cell lines. However, as transcription signals are similar at the 3' end of the DNA-PK cs gene, productive transcription from this gene is the same in the J and K lines.
The dierent probes used in our run-on experiments required dierent exposure times for optimal band density. Whereas the histone H2b and g-actin probes gave strong signals after only 6 h, myc required 24 h. Signi®cantly, no visible signal was observed with any of the three DNA-PK cs sense probes before one week of exposure ( Figure 3 ). These results indicate that the rate of DNA-PK cs transcription is very low compared to many other genes. Surprisingly, a signi®cant transcription signal complementary to the mid-DNA-PK cs probe was detected. We have not yet ascertained whether there is an anti-sense ORF in this region or whether this anti-sense mRNA has any regulatory signi®cance. However, the mid-DNA-PK cs gene region is transcribed in the anti-sense direction to the same extent in both M059J and M059K cells ( Figure 3 ) and in both cell a b Figure 2 Analysis of mRNA levels in M059J and M059K cells by quantitative RT ± PCR. (a) Ethidium bromide-stained agarose gel analyses of DNA-PK cs (ampli®ed using the primer pair PK19-PK20) and b-actin (ampli®ed using BA-67 and BA-68) ampli®ed from serially diluted cDNA templates prepared from RNA extracted from M059J (shown as the left dilution series in this ®gure) or M059K cells (shown as the right dilution series in this ®gure). Similar results were obtained with other DNA-PK cs cDNA-speci®c primer pairs (b) Graphical analysis of ®ve independent RT ± PCR experiments. Error bars show the range of values. PCR for each set of probes were performed concurrently, albeit in reaction separate tubes; reaction products from each were analysed on the same gel Figure 3 Rate of DNA-PK cs transcription in M059J and M059K cells determined by run-on transcriptional analysis. Nuclei were isolated from cells and newly synthesized transcripts were labeled with a 32 P-UTP. One mg of several single-stranded sense and antisense probes was immobilized to ®lters and hybridized to the runo transcripts. Although all probes shown in this ®gure were present on the same ®lter, dierent probes required dierent lengths of time for optimal exposure. Thus this ®gure is a composite of autoradiograms. 5'DNA-PK cs : nt 473 ± 1049 of the DNA-PK cs cDNA; midDNA-PK cs : nt 6102 ± 6445; 3'DNA-PK cs : nt 11 893 ± 12 455; myc E1: exon one of c-myc; gA3':3' region of g-actin; H2b: histone 2b. All probes were made by insertion of the cDNA speci®c sequences into the MCS of M13mp18 and M13mp19, followed by isolation of ss M13 DNA. Sense probes for 5'DNA-PK cs and 3'DNA-PK cs and the antisense midDNA-PK cs probe were generated from M13mp18 derivatives. Antisense probes for 5'DNA-PK cs and 3'DNA-PK cs and the sense midDNA-PK cs probe were prepared from M13mp19 derivatives lines the resultant transcripts are highly unstable (data not shown).
The DNA-PK cs transcript has signi®cantly reduced stability in M059J cells as compared to M059K cells or the normal human ®broblast strain, GM38
Because the DNA-PK cs gene is transcribed at similar rates in both glioma cell lines, the most probable explanation for the *20-fold lower steady-state level of DNA-PK cs transcripts in M059J cells is an alteration in stability of the mRNA. We therefore arrested RNA synthesis by incubating cells with actinomycin D and subsequently determined the relative number of DNA-PK cs and b-actin transcripts in 1 mg of total RNA at various times following treatment by quantitative PCR. cDNAs prepared from total RNA extracted from each post-treatment cell sample were serially diluted and PCR performed on an aliquot of each dilution as described for Figure 3 . The results presented in Figure 4 show data generated using the PK19 ± PK20 primer pair; primer pairs complementary to sequences at the extreme 5' end or in the center of the transcript gave indistinguishable results. Per mg of total RNA, b-actin mRNA is equally stable in M059J and M059K cells (Figure 4a ), a result that is consistent with our previous Northern analysis showing that the steady state levels of b-actin mRNA are equivalent in these two cell lines (LeesMiller et al., 1995) . The b-actin transcript is similarly stable in GM38 cells (data not shown). We then determined the amount of DNA-PK cs mRNA in M059K cells at dierent times relative to b-actin mRNA ( Figure 4b ) and found that the DNA-PK cs mRNA is also very stable in M059K cells with a halflife comparable to that of b-actin. No signi®cant decrease in the amount of either transcript per mg of total cellular RNA occurred until approximately 24 h following the addition of actinomycin D. Comparable DNA-PK cs transcript stability was observed in GM38 cells (data not shown). In contrast, the DNA-PK cs transcript levels in M059J cells dropped to less than 50% of the level in untreated cells by 6 h posttreatment, and to less than 25% by 12 h (Figure 5a and b). Note that this is a measure of relative half-life per mg of total cellular RNA; since all cellular RNA is decreasing in abundance following actinomycin D treatment, the true half-life of a particular species cannot be determined using this technique. However, given that the b-actin transcript has a true half-life of approximately 24 h (Belasco and Brawerman, 1993) , the true half-life of the DNA-PK cs mRNA is approximately 24 h in M059K and GM38 cells but less than 1.5 h in M059J cells.
To corroborate the mRNA half-life measurements made in the presence of actinomycin D, we attempted to measure the loss of 3 H-uridine from DNA-PK cs transcripts with time following removal of the radioactive label from the medium. Because the rate of DNA-PK cs transcription as determined by nuclear runon transcription analysis is very low, a long labeling time was required to accumulate sucient radioactivity in DNA-PK cs transcripts. M059J cells are, however, very sensitive to ionizing radiation (Allalunis-Turner et al., 1993); thus, there were very few surviving cells even at 24 h when the uridine label was removed. The radiation sensitivity of M059J cells is associated with apoptosis (unpublished data) and the breakdown of all nucleic acids during apoptosis made interpretation of data from this experiment impossible.
M059J cells do not contain the alternative spliced DNA-PK cs transcript
Although the mature 13.5 kb DNA-PK cs mRNA is assembled from approximately 90 small exons by splicing to remove several hundred kb of intron transcript, only one alternatively spliced mRNA has been described (Blunt et al., 1996; Connelly et al., 1996) . The smaller transcript, which lacks a 93 nt exon in the kinase domain, was identi®ed as a splicing variant found at a low level (*5%) in cell lines with dierent origins, including epithelial cells, ®broblasts and lymphocytes (Blunt et al., 1996; Connelly et al., 1996) . Since alternate splicing is often tissue speci®c and can have functional and regulatory signi®cance, we checked several of our glioma cell lines to ascertain which forms of the transcript was present in these cells. RT ± PCR with primers PK19 and PK20, which are identical to those initially used to uncover the splicing variation except for omission of the non-homologous EcoRI cloning site (Connelly et al., 1996) revealed a 299 bp product, the expected fragment from the larger Figure 6) . Surprisingly, a 206 bp RT ± PCR product, which is indicative of a transcript lacking the 93 nt exon, was present in all cases with the sole exception of reactions which used RNA isolated from M059J cells (Figure 6 ). The proportion of the two forms varies in the dierent cells, accounting for *20% of DNA-PK cs transcripts in M059K cells and another glioma cells line, M016, but less than 10% of DNA-PK cs transcripts in the bladder carcinoma cell line, F7112/cp, in the normal human skin ®broblast strain, GM38 and in normal lymphocytes (quantitative analysis not shown).
To support our hypothesis that the failure to detect the shorter transcript in M059J cells was due to its absence rather than low abundance, we added decreasing amounts of a second competing substrate to ampli®cation reactions using M059J cDNA as the primary substrate. This single-stranded DNA was made by cloning into M13mp18 a BamHI ± HindIII PCR fragment corresponding to DNA-PK cs cDNA fragment nt 10 404 ± 11 787, which encompasses the alternate splice site. A foreign fragment was then inserted into the PstI site, generating a molecule which, when ampli®ed by the same primer pair used to detect the alternatively spliced transcripts (PK19 ± PK20), results in a distinctive 680 bp product. A product of the appropriate size was evident even when the abundance of this second molecule was 50.2% of the M059J DNA-PK cs cDNA level (data not shown).
The kinase domain, the 3'UTR, and the ®rst 1538 nucleotides of the DNA-PK cs transcript in M059J cells have no sequence alteration
The 3'-non-coding region of several genes contain sequences which confer stability or instability (Nanbu et al., 1994; Schiavi et al., 1994; Chen et al., 1996; Edwalds-Gilbert et al., 1997) . Therefore, we sequenced the 3'UTR of DNA-PK cs with the hope of uncovering a mutation that destabilizes the mRNA. Because we were unable to ®nd any DNA-PK activity in these cells, we also sequenced the kinase domain. RT ± PCR products from M059J and M059K cells were generated with two DNA-PK cs -speci®c primers, PK23 and PK27 and these fragments were sequenced using additional internal gene-speci®c primers. The resulting 2221 bp segments from M059J and M059K cells, corresponding to the sequence between nucleotides 11 200 and 13 420 of the DNA-PK cs cDNA were identical to that of the published sequence data not shown) .
A mRNA can be rendered unstable by the presence of a nonsense mutation, normally in the ®rst two-thirds of a gene (Lim et al., 1992; Belgrader et al., 1993; Hagan et al., 1995; Yun and Sherman, 1995; . We have, therefore, undertaken to sequence the remainder of the DNA-PK cs cDNA derived from M059J and K cells. RT ± PCR products from M059J and M059K cells were generated with two DNA-PK csspeci®c primers, PK10 and PK40 and these 1504 bp fragments, corresponding to the region between nucleotides 89 and 1573 of the DNA-PK cs cDNA, were sequenced using additional internal gene-speci®c primers. For both M059J and K, all sequence Results shown here are derived from at least three independent experiments for each comparison of b-actin vs DNA-PK cs mRNA and M059J vs M059K cells. Measurements were normalized to one mg of total RNA; thus these data illustrate the relative amounts of two mRNAs at various post-treatment times and do not re¯ect the true half-lives Figure 6 M059J cells lack the alternatively spliced DNA-PK cs mRNA. A segment of the DNA-PK cs cDNA, which encompasses the alternative splice site, was ampli®ed by RT ± PCR. Full-length transcripts generate a 299 bp fragment, while the shorter transcript lacking the 93 nt exon generates a 206 bp fragment. Shown are the products obtained from normal lymphocytes (Normal), the M016 glioma cell line, the F7112/cp bladder carcinoma cell line, M059J and M059K. Note that larger *400 bp fragment observed in some lanes is a non-speci®c RT ± PCR product, as deduced by sequence analysis generated was identical to the published sequence data not shown) . Thus, the sequence of the ®rst 1538 nucleotides, the entire kinase domain and most of the 3'UTR of the DNA-PK cs mRNA from M059J is identical to that from M059K cells. Further sequence analysis is currently underway.
The kinase domain encompasses the 93 bp exon that is omitted from alternately spliced transcripts. Blunt et al. (1996) suggested that the sequence GTTAGC, which is similar to the sequence GGTTAGG at the beginning of this exon, may act as a splice donor site, thereby causing the exon to be omitted from some transcripts. In mouse, the corresponding sequence, GATTAGG, is signi®cantly less similar to the splice donor consensus, and in mouse cells the alternately spliced product is absent. However, the absence of the shorter, alternatively spliced mRNA in M059J cells cannot be attributed to a sequence change within this putative splice donor site or anywhere else within the three exons involved in alternative splicing as the exon sequences from both M059J and M059K cells are identical to each other and to the published cDNA sequence. Additionally, we sequenced a *700 bp genomic segment from M059J and M059K cells that encompasses the 93 bp exon, the proximal portion of the following intron, the preceding intron, and the preceding exon. Again, the sequences from both cell lines were identical (data not shown).
Discussion
We previously showed that the absence of DNA-PK cs protein and DNA-PK activity account for the radiosensitive phenotype of our human glioma cell line, M059J . Here we present data showing that the defect in these cells is not due to a failure to express DNA-PK cs mRNA as previously thought. Instead, M059J cells synthesize this transcript at a rate comparable to that in their radioresistant, DNA-PK-pro®cient counterpart, M059K, isolated from the same glioma biopsy. However, the 20-fold lower level of DNA-PK cs mRNA in M059J cells can be attributed to its signi®cantly shorter half-life. The stability of the DNA-PK cs transcript in M059K and GM38 cells is comparable to that of b-actin mRNA, which is relatively stable with a half-life of approximately 24 h (Belasco and Brawerman, 1993) . In M059J cells, the half-life is reduced 20-fold, which would correspond to less than 1.5 h. We sequenced approximately 800 bp in the promoter region, 1.5 kb of the 5' coding region and 2.22 kb of the 3' region of the DNA-PK cs cDNA from both cell lines and were unable to ®nd a sequence dierence that accounts for the instability of this transcript in M059J cells. Therefore, we have eliminated sequence changes in the promoter region, the ®rst 1538 nucleotides of the cDNA, the C-terminal kinase domain, and 3' UTR as the source of transcript instability in M059J cells.
Besides the change in DNA-PK cs mRNA stability, the only notable dierence between M059J and M059K cells we have observed is an absence of the shorter, alternately spliced message in the radiosensitive M059J cells. This mRNA, thought to be produced through an alternative splicing event, lacks a 93 bp exon in the PI kinase domain (Blunt et al., 1996; Connelly et al., 1996) . Although it might be assumed that this shorter transcript is non-functional, as it deletes 31 amino acids from the conserved region of the PI 3-kinase superfamily, Blunt et al. (1996) suggested that it may have a regulatory function. This possibility is strengthened by our ®ndings reported here. First, the ratio of the two spliced forms is dierent in dierent human tissue types and cell lines (Blunt et al., 1996; Connelly et al., 1996 ; this paper). Second, presence of the shorter transcript correlates with stability of the longer, functional transcript, suggesting a possible role for the shorter transcript in stabilizing the longer transcript. Several means by which this stabilization may occur can be envisioned. For example, the shorter transcript may preferentially bind and sequester destabilizing factors through sequence or secondary structure features unique to the shorter transcript.
A second possibility that could account for the instability of the DNA-PK cs transcription in M059J cells that we have not discounted is a mutation in sequences downstream of nucleotide 1538 and upstream of the kinase domain. As alluded to previously, it is well documented that a mRNA can be rendered unstable by the presence of a nonsense mutation in the ®rst two-thirds of a gene, typically by uncovering a sequence which is viewed as an instability element when untranslated (Lim et al., 1992; Belgrader et al., 1993; Hagan et al., 1995; Yun and Sherman, 1995; Zhang et al., 1995) . We currently are using an expression system to determine whether a nonsense mutation is present, and we are continuing eorts to sequence additional exons and surrounding segments from the M059J and M059K cell lines. A third, intriguing possibility is a genetic change in M059J cells unrelated to the DNA-PK cs gene that aects a trans-acting factor (or its expression) necessary for stabilizing the DNA-PK cs , and perhaps other transcripts. We are continuing to investigate the reason for the instability of DNA-PK cs mRNA in M059J cells, but these studies are hampered by the extremely poor transfection rate (55%) of both M059J and K cells and the large size of the DNA-PK cs cDNA.
DNA-PK activity is essential to cells that are exposed to agents which cause double-strand DNA breaks, as evident from the radiosensitive phenotype of M059J cells (Allalunis-Turner et al., 1993) . DNA-PK is interesting, therefore, as a potential target for novel drugs in cancer therapy. Pharmaceuticals that inactivate DNA-PK would have potential use as an adjunct to radiation therapy. Nevertheless, to develop eective therapies, it is imperative to understand how expression of this enzyme is regulated. Here we have shown that while the DNA-PK cs gene is transcribed at an exceptionally low rate, the mRNA normally is very stable. However, our studies also show that destabilization of the DNA-PK cs mRNA is sucient to manifest a radiosensitive phenotype, suggesting a possible alternative approach to manipulating DNA-PK activity for cancer therapy. Finally, the correlation in M059J cells between the reduced stability of the DNA-PK cs transcript and the lack of a shorter alternate transcript leaves open the intriguing possibility that the shorter transcript plays a role in stabilizing the full-length transcript.
Materials and methods
Cell lines
Normal lymphocytes were isolated from human blood by the Ficoll-Paque method (Pharmacia). The M016, M059J and M059K cell lines were established in our laboratory from human glioma biopsies (Allalunis-Turner et al., 1993) . M059J and M059K were established from the same biopsy. M059J is extremely radiation-sensitive whereas M059K and M016 show a normal response to radiation (Allalunis-Turner et al., 1993) . GM38, a normal human skin ®broblast strain, was purchased from the NIGMS Human Genetic Mutant Cell Repository (Camden, NJ, USA). F7112/cp, a cell line derived from a human bladder carcinoma, was kindly donated by Dr Richard Britten. All cells were maintained in Dulbecco's modi®ed Eagle's/F12 medium containing 10% fetal calf serum and 2 mM Lglutamine. . Several other sequencing primers were used which are internal to the PCR products generated by PK23 and PK27 or PK5 and PK7. The bactin primers (BA-67 and BA-68) are described by Horikoshi et al. (1992) .
PCR Primers
DNA-PK
PCR, RT ± PCR and quantitative PCR
Cells were grown to mid-log phase and harvested by trypsinization. Total RNA was isolated using the RNAeasy Mini kit system (Qiagen). cDNA was synthesized from 1 mg of total RNA using a T 12 MN primer, Superscript II (Gibco/BRL), and conditions set out by the manufacturer.
PCR was performed using gene-speci®c primers and 0.1 mg of SacI ± KpnI digested genomic DNA or 0.5 ml of a cDNA reaction. PCR conditions were as follows: 50 mM KCl, 10 mM Tris-HCl, pH 8.4, 3.0 mM MgCl 2 , 0.4 mM dNTPs, 0.1 mM primer 1, 0.1 mM primer 2, and 0.02 units/ml Taq Polymerase (Pharmacia) with cycling conditions of 948C for 3 min followed by 40 cycles of: 1 min at 948C, 2 min at 558C and 1 min at 728C. Reactions were analysed by agarose gel/ ethidium bromide staining.
For quantitative PCR, conditions were as above with the following exceptions. Each cDNA product was serially diluted (2 72 to 2 716 ) and 0.5 ml of these dilutions were used as templates for simultaneously performed PCRs with either DNA-PK cs -speci®c or b-actin-speci®c primers. Cycling conditions were identical to those set out above except that the number of cycles was reduced (28 for bactin primers and 33 for DNA-PK cs primers). Agarose gels (2%) were ethidium bromide stained and analysed by photographic imaging followed by densitometric quantitation using the alphaImager 2000 system (Alpha Innotech Corp.).
Nuclear run-on transcription assays
Cells were harvested by trypsinization and washed twice with phosphate-buered saline and once with a saline buer containing (10 mM NaCl, 10 mM Tris pH 7.4 and 5 mM MgCl 2 . After resuspending in the same saline buer, NP-40 was added to 0.5% and cells were lysed in a cold tissue homogenizer. Nuclei were recovered at 1000 g for 5 min at 48C and frozen at 7708C in nuclear freezing buer (50 mM Tris, pH 8.0, 5 mM MgCl 2 , 40% glycerol, 0.5 mM DTT). Transcription was continued in a standard nuclear run-o reaction (Spencer et al., 1997) containing 1610 7 nuclei and 300 mCi [a 32 P]UTP (3000 mCi/mmole; Amersham). After removal of DNA, proteins and unincorporated radioactive nucleotides, reactions were allowed to hybridize (2 days at 658C) to 1 mg of each ssDNA gene-speci®c probe which had been immobilized onto Genescreen + (DuPont) ®lters through a slot blotting apparatus. After non-hybridized radioactive RNA was digested and washed from the resultant ®lters, they were exposed to X-ray ®lm for 6, 24 h and 9 days.
To prepare single-stranded (ss) probes for DNA-PK cs , RT ± PCR products were digested with appropriate restriction enzymes and cloned into the multiple cloning site (MCS) of both M13mp18 and M13mp19 (Gibco/BRL), which allowed isolation of both sense and anti-sense single-stranded probes. The`5'DNA-PK cs ' probe contains nt 473 ± 1049, the`midDNA-PK cs , probe includes nt 6102 ± 6445 and the`3' DNA-PK cs probe' contains nt 11 893 ± 12 455 of the published cDNA sequence . Single-stranded M13mp18 and M13mp19 DNAs containing DNA-PK cs inserts were then isolated using a QIAprep Spin M13 kit (Qiagen) generating both sense and anti-sense probes for each sequence. The presence of each insert was veri®ed by sequencing. The uridine content of mRNA in each probe region was: 5' (sense) 30.2%, 5' (antisense) 28.4%, mid (sense) 24.6%, mid (antisense) 24.4%, 3' (sense) 27.6%, 3' (antisense) 21.7%. The mycE1, gactin 3' and H2b single-stranded probes have been described (Spencer et al., 1997) and detect either sense or antisense transcription from the human c-myc gene (exon 1), the human g-actin gene (exons 4 ± 6) and the human histone H2b gene.
Measurement of mRNA decay rates using actinomycin D Cells were seeded into¯asks and grown to mid-log phase; they then were washed with PBS and serum-free medium containing 7.5 mg/ml of actinomycin D (Merck & Co.) was added. Cells were harvested by trypsinization at 0, 6, 12, 24 and 48 h following treatment. Total RNA was isolated using the RNAeasy Mini kit system (Qiagen) and analysed by quantitative RT ± PCR.
Sequencing
A PCR product corresponding to genomic DNA spanning the DNA-PK cs promoter region was prepared using the primer pair PK5 ± PK7. A 5' segment of the cDNA was similarly prepared by RT ± PCR using the primer pair PK10 ± PK40 and a 3' segment using the primer pair PK23 ± PK27. PCR products were sequenced using [a 35 S]dATP (1000 mCi/mmol; Amersham), the Thermosequence cycle sequencing kit (Amersham) and internal genespeci®c primers derived from the published sequence. Sequences were analysed on a 6% polyacrylamide gel.
